The ATF6-Met [67] Val substitution is associated with increased plasma cholesterol levels

S.J. Meex, D. Weissglas-Volkov, C.J. Kallen, D.J. Thuerauf, M.M. Greevenbroek, C.G. Schalkwijk, C.D. Stehouwer, E.J.M. Feskens, J. Heldens, T.A. Ayoubi, M.H. Hofker, B.G. Wouters, R. Vlietinck, J.S. Sinsheimer, M.R. Taskinen, J. Kuusisto, K. Laakso, T.W. Bruin, P. Pajukanta, C.C. Glembotski

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)

Abstract

Objective— Activating transcription factor 6 (ATF6) is a sensor of the endoplasmic reticulum stress response and regulates expression of several key lipogenic genes. We used a 2-stage design to investigate whether ATF6 polymorphisms are associated with lipids in subjects at increased risk for cardiovascular disease (CVD). Methods and Results— In stage 1, 13 tag-SNPs were tested for association in Dutch samples ascertained for familial combined hyperlipidemia (FCHL) or increased risk for CVD (CVR). In stage 2, we further investigated the SNP with the strongest association from stage 1, a Methionine/Valine substitution at amino-acid 67, in Finnish FCHL families and in subjects with CVR from METSIM, a Finnish population-based cohort. The combined analysis of both stages reached region-wide significance (P=9x10–4), but this association was not seen in the entire METSIM cohort. Our functional analysis demonstrated that Valine at position 67 augments ATF6 protein and its targets Grp78 and Grp94 as well as increases luciferase expression through Grp78 promoter. Conclusions— A common nonsynonymous variant in ATF6 increases ATF6 protein levels and is associated with cholesterol levels in subjects at increased risk for CVD, but this association was not seen in a population-based cohort. Further replication is needed to confirm the role of this variant in lipids. We report the association of the ATF6-methionine [67]valine amino-acid substitution with plasma cholesterol levels. Association analyses in 2674 subjects and functional data suggest that the ATF6 gene may influence cholesterol levels in subjects at increased risk to develop cardiovascular disease.
Original languageEnglish
Pages (from-to)1322-1327
JournalArteriosclerosis Thrombosis and Vascular Biology
Volume29
DOIs
Publication statusPublished - 2009

Keywords

  • transcription factor
  • in-vivo
  • stress
  • domain
  • activation
  • atf6
  • degradation
  • binding
  • er

Fingerprint Dive into the research topics of 'The ATF6-Met [67] Val substitution is associated with increased plasma cholesterol levels'. Together they form a unique fingerprint.

Cite this